Connie Wen, Yixun Wang, Kyungsene Lee, Xuelin Wang, Yong Wang
{"title":"核酸适配体中和酶的dna触发激活原位形成可注射水凝胶。","authors":"Connie Wen, Yixun Wang, Kyungsene Lee, Xuelin Wang, Yong Wang","doi":"10.1039/d5nh00314h","DOIUrl":null,"url":null,"abstract":"<p><p>Injectable hydrogels have been widely studied for the embolization of vascular malformations and the control of bleeding in hemorrhages. An ideal injectable hydrogel in these applications needs to form once contacting with the blood components, which enables easy control of hydrogel formation and injectability. However, this type of injectable hydrogel has not yet been widely studied. In this work, an injectable hydrogel system was developed by using a bispecific aptamer-neutralized enzyme and a triggering DNA. The results show that the system remained in its solution or pre-gelation state in the presence of the bispecific aptamer. Upon contact with the triggering DNA, the system was transformed into a hydrogel state. <i>In vitro</i> aneurysm and endovascular embolization were further conducted, and the results showed the DNA administered out of the hydrogel system could trigger the activation of aptamer-bound enzymes for the accelerated formation of the injectable hydrogel. Therefore, this study has successfully demonstrated that a bispecific aptamer-neutralized enzyme in the pre-gelation system can be rapidly released to accelerate the formation of injectable hydrogels when the system is in contact with the blood that contains a triggering DNA.</p>","PeriodicalId":93,"journal":{"name":"Nanoscale Horizons","volume":" ","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169211/pdf/","citationCount":"0","resultStr":"{\"title\":\"DNA-triggered activation of aptamer-neutralized enzyme for <i>in situ</i> formation of injectable hydrogel.\",\"authors\":\"Connie Wen, Yixun Wang, Kyungsene Lee, Xuelin Wang, Yong Wang\",\"doi\":\"10.1039/d5nh00314h\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Injectable hydrogels have been widely studied for the embolization of vascular malformations and the control of bleeding in hemorrhages. An ideal injectable hydrogel in these applications needs to form once contacting with the blood components, which enables easy control of hydrogel formation and injectability. However, this type of injectable hydrogel has not yet been widely studied. In this work, an injectable hydrogel system was developed by using a bispecific aptamer-neutralized enzyme and a triggering DNA. The results show that the system remained in its solution or pre-gelation state in the presence of the bispecific aptamer. Upon contact with the triggering DNA, the system was transformed into a hydrogel state. <i>In vitro</i> aneurysm and endovascular embolization were further conducted, and the results showed the DNA administered out of the hydrogel system could trigger the activation of aptamer-bound enzymes for the accelerated formation of the injectable hydrogel. Therefore, this study has successfully demonstrated that a bispecific aptamer-neutralized enzyme in the pre-gelation system can be rapidly released to accelerate the formation of injectable hydrogels when the system is in contact with the blood that contains a triggering DNA.</p>\",\"PeriodicalId\":93,\"journal\":{\"name\":\"Nanoscale Horizons\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.0000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169211/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanoscale Horizons\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1039/d5nh00314h\",\"RegionNum\":2,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, PHYSICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanoscale Horizons","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1039/d5nh00314h","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
DNA-triggered activation of aptamer-neutralized enzyme for in situ formation of injectable hydrogel.
Injectable hydrogels have been widely studied for the embolization of vascular malformations and the control of bleeding in hemorrhages. An ideal injectable hydrogel in these applications needs to form once contacting with the blood components, which enables easy control of hydrogel formation and injectability. However, this type of injectable hydrogel has not yet been widely studied. In this work, an injectable hydrogel system was developed by using a bispecific aptamer-neutralized enzyme and a triggering DNA. The results show that the system remained in its solution or pre-gelation state in the presence of the bispecific aptamer. Upon contact with the triggering DNA, the system was transformed into a hydrogel state. In vitro aneurysm and endovascular embolization were further conducted, and the results showed the DNA administered out of the hydrogel system could trigger the activation of aptamer-bound enzymes for the accelerated formation of the injectable hydrogel. Therefore, this study has successfully demonstrated that a bispecific aptamer-neutralized enzyme in the pre-gelation system can be rapidly released to accelerate the formation of injectable hydrogels when the system is in contact with the blood that contains a triggering DNA.
期刊介绍:
Nanoscale Horizons stands out as a premier journal for publishing exceptionally high-quality and innovative nanoscience and nanotechnology. The emphasis lies on original research that introduces a new concept or a novel perspective (a conceptual advance), prioritizing this over reporting technological improvements. Nevertheless, outstanding articles showcasing truly groundbreaking developments, including record-breaking performance, may also find a place in the journal. Published work must be of substantial general interest to our broad and diverse readership across the nanoscience and nanotechnology community.